학술논문

Effects of eight-week regular high-intensity interval training and hemp (Cannabis sativa L.) seed on total testosterone level among sedentary young males: double-blind, randomized, controlled clinical trial
Document Type
Original Paper
Source
Endocrine: International Journal of Basic and Clinical Endocrinology. 84(1):273-286
Subject
Regular exercise
High-intensity interval training
Hemp seed
Testosterone levels
Antioxidant
Sedentary lifestyle
Language
English
ISSN
1559-0100
Abstract
Purpose: This study aimed to investigate the effects of high-intensity interval training (HIIT) alone or in combination with hemp seed on total testosterone (TT) levels, sex hormone-binding globulin (SHBG), body composition, oxidative stress, and antioxidant capacity in sedentary young males.Methods: Randomly, 48 young sedentary males were assigned among four groups (each comprising 12 individuals) as follows: HIIT + hemp seed (HH), HIIT + placebo (AT), hemp seed only (HS), and control. For eight weeks, exercise groups had HIIT three times per week. Hemp seed groups received 2 g of powder daily. The plasma levels of TT, SHBG, catalase (CAT), superoxide dismutase (SOD), malondialdehyde (MDA), and also body mass index (BMI), body fat percentage (BF%), and muscle mass percentage (MM%) were measured. The analysis was based on the intention-to-treat (ITT) and per-protocol (PP).Results: Based on ITT, BMI and BF% decreased, and MM% increased significantly post-intervention in HIIT groups (p < 0.05). TT increased significantly in the HH [mean difference 0.45, 95% CI 0.1 to 0.7, p = 0.005] and AT [mean difference 0.37, 95% CI 0.1 to 0.7, p = 0.01]. The whole hemp seed components showed a significant antioxidant potential. However, none of the SOD, CAT, and MDA indices showed significant changes post-interventions (p ≥ 0.05).Conclusion: Finally, HIIT and hemp seed intake showed no significant effects on the antioxidant defense system. However, regular HIIT significantly increased TT levels and improved body composition in sedentary young males.Trial registration: Iranian Registry of Clinical Trials (registration code: IRCT20140907019082N10).